Medical Marijuana, Inc. MJNA has announced its financial results for the year ending December 31, 2021, and provided an overview of recent operational highlights.
Q3 2021 Financial & Operational Highlights
- Generated $34.1 million in net revenue for fiscal year 2021.
- Gross profit fiscal year 2021, was $26.9 million representing a gross profit margin of 78%.
- Total cash balance at year end was $5.4 million.
- Medical Marijuana, Inc. experienced substantial growth in its international business segments including the establishment of operations in South Africa and Hong Kong, and celebrated sales growth records in its Japanese, Brazilian and Mexican businesses.
- Added key executive team members with deep experience in high-growth, international companies;
- Increased its advocacy of expanded access to cannabis-based products through participation in industry organizations and supportive stances on regulatory changes in favor of cannabis legalization around the world.
“2021 was a pivotal year for Medical Marijuana, Inc – a year focused on our mission to establish new markets internationally and to bring access to safe and effective cannabis-based products to millions worldwide,” Blake Schroeder, the company’s CEO, said. “I’m proud of the progress we made in achieving that mission. Medical Marijuana, Inc. is leading the way in becoming the first global cannabis company. We will continue to utilize our first mover advantage in these markets while optimizing and growing our existing operations.”
Price Action
Medical Marijuana’s shares traded 7.4074% higher at $0.0261 per share at the time of writing.
Related News
- Medical Marijuana Eliminates $10M Of Debt From Its Balance Sheet
- Medical Marijuana's Kannaway To Launch Its First CBD Product With 1% THC At Its Event In Prague
- Medical Marijuana's HempMeds Brasil Sponsors Brazilian Obesity Medicine Symposium
- Medical Marijuana's Subsidiary Kannaway Reveals Record Revenue Month For South Africa And Japan Divisions
Photo: Courtesy of Chris Briggs on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!